Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$688K Sell
82,866
-187,436
-69% -$1.75M ﹤0.01% 2410
2026
Q1
$2.87M Buy
270,302
+9,332
+4% +$116K 0.01% 1357
2025
Q4
$3.1M Sell
260,970
-135,898
-34% -$1.48M 0.01% 1027
2025
Q3
$3.38M Buy
396,868
+253,918
+178% +$1.93M 0.01% 864
2025
Q2
$1.05M Buy
142,950
+120,153
+527% +$885K ﹤0.01% 1245
2025
Q1
$160K Buy
+22,797
New +$357K ﹤0.01% 2073
2024
Q4
Sell
-43,445
Closed -$1.07M 2408
2024
Q3
$1.07M Buy
+43,445
New +$1.13M 0.01% 1204
2024
Q1
Sell
-18,273
Closed -$752K 2283
2023
Q4
$752K Buy
+18,273
New +$427K 0.01% 1132
2022
Q4
Sell
-69,572
Closed -$3.1M 2443
2022
Q3
$3.1M Buy
69,572
+54,102
+350% +$2.63M 0.03% 450
2022
Q2
$651K Buy
15,470
+8,621
+126% +$433K 0.01% 1296
2022
Q1
$460K Buy
+6,849
New +$467K ﹤0.01% 1897

Other funds holding ARVN

HRT Financial's ARVN Position: Q2 2026 in Review

HRT Financial reduced its Arvinas (ARVN) stake by 69% in Q2 2026, selling an estimated $1.75M and leaving 82,866 shares worth $688K. The position accounts for ﹤0.01% of the portfolio, ranked #2410.

HRT Financial first reported a position in ARVN in Q1 2022 and has held it in 11 quarters since. The position peaked at $3.38M in Q3 2025. 200 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

  • HRT Financial held 82,866 shares of Arvinas worth $688K as of Q2 2026.
  • HRT Financial sold 187,436 Arvinas shares in Q2 2026, an estimated $1.75M.
  • Arvinas made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2410 holding.
  • HRT Financial first reported a position in Arvinas in Q1 2022 and has held it in 11 quarters since.
  • HRT Financial's Arvinas position peaked at $3.38M in Q3 2025.
  • 200 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.